SCHEMBL5597387

SCHEMBL5597387

CCn1c(=O)c(NC(=O)c2c[nH]nc2Cc2cccc(F)c2)c(N)n(C)c1=O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.39
ADORA2B P29275 2/20 0.39
ADORA1 P30542 2/20 0.39
ADORA3 P0DMS8 1/20 0.39
MEN1 O00255 2/20 0.37
LMNA P02545 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 2/20 0.37
PARP1 P09874 3/20 0.36
DHODH Q02127 6/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
FSCN1 Q16658 1/20 0.35
PDE10A Q9Y233 1/20 0.35
PCSK9 Q8NBP7 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5059236 0.90 ADORA2A (0.42) ADORA2AADORA2BADORA1ADORA3MEN1
SCHEMBL5054303 0.80 ADORA2B (0.42) ADORA2AADORA2BADORA1ADORA3MEN1
SCHEMBL5597238 0.80 ADORA3 (0.44) ADORA2AADORA2BADORA1ADORA3MEN1
SCHEMBL1546750 0.75 ADORA2B (0.52) ADORA2AADORA2BADORA1ADORA3
SCHEMBL6856480 0.69 HCAR2 (0.54) PARP1PDE10A
SCHEMBL5779014 0.69 PDE3B (0.49) LMNAGAAPDE3BPDE3AMAPT
SCHEMBL6014101 0.68 ADORA2B (0.40) ADORA2AADORA2BADORA1ADORA3MEN1
SCHEMBL1546533 0.67 ADORA2B (0.54) ADORA2AADORA2BADORA1ADORA3MEN1
SCHEMBL1546111 0.66 ADORA2A (0.55) ADORA2AADORA2BADORA1ADORA3
SCHEMBL1546032 0.63 ADORA2B (0.54) ADORA2AADORA2BADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799221-A1 METHOD OF PREVENTING AND TREATING AIRWAY REMODELING AND PULMONARY INFLAMMATION USING A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2007-06-27 EP disclosed
WO-2006044610-A1 METHOD OF PREVENTING AND TREATING AIRWAY REMODELING AND PULMONARY INFLAMMATION USING A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC (US) 2006-04-27 WO disclosed